Search Results - "SPERNOVASILIS, NIKOLAOS"

Refine Results
  1. 1

    COVID-19 and antimicrobial stewardship: What is the interplay? by Spernovasilis, Nikolaos A, Kofteridis, Diamantis P

    “…[...]antimicrobials are being used in empirical or targeted treatment for co- or superinfection outside the respiratory tract. [...]most data regarding…”
    Get full text
    Journal Article
  2. 2

    Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome by Samonis, George, Karageorgopoulos, Drosos E, Maraki, Sofia, Levis, Panagiotis, Dimopoulou, Dimitra, Spernovasilis, Nikolaos A, Kofteridis, Diamantis P, Falagas, Matthew E

    Published in PloS one (18-05-2012)
    “…Stenotrophomonas maltophilia is acquiring increasing importance as a nosocomial pathogen. We retrospectively studied the characteristics and outcome of…”
    Get full text
    Journal Article
  3. 3

    Emerging and Re-Emerging Infectious Diseases: Humankind's Companions and Competitors by Spernovasilis, Nikolaos, Tsiodras, Sotirios, Poulakou, Garyphallia

    Published in Microorganisms (Basel) (04-01-2022)
    “…Infectious disease outbreaks had a significant impact on shaping the societies and cultures throughout human history [...]…”
    Get full text
    Journal Article
  4. 4

    Mediterranean Spotted Fever: Current Knowledge and Recent Advances by Spernovasilis, Nikolaos, Markaki, Ioulia, Papadakis, Michail, Mazonakis, Nikolaos, Ierodiakonou, Despo

    Published in Tropical medicine and infectious disease (24-09-2021)
    “…Mediterranean spotted fever (MSF) is an emerging tick-borne rickettsiosis of the spotted fever group (SFG), endemic in the Mediterranean basin. By virtue of…”
    Get full text
    Journal Article
  5. 5

    Pre-Existing Liver Disease and Toxicity of Antifungals by Spernovasilis, Nikolaos, Kofteridis, Diamantis P

    Published in Journal of fungi (Basel) (10-12-2018)
    “…Pre-existing liver disease in patients with invasive fungal infections further complicates their management. Altered pharmacokinetics and tolerance issues of…”
    Get full text
    Journal Article
  6. 6

    Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence by Karniadakis, Ioannis, Mazonakis, Nikolaos, Tsioutis, Constantinos, Papadakis, Michail, Markaki, Ioulia, Spernovasilis, Nikolaos

    Published in Infectious disease reports (25-10-2023)
    “…Vaccines remain the cornerstone of medical prevention and are highly effective in reducing the risk of severe disease and death due to coronavirus disease 2019…”
    Get full text
    Journal Article
  7. 7

    Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual by Schinas, Georgios, Polyzou, Elena, Spernovasilis, Nikolaos, Gogos, Charalambos, Dimopoulos, George, Akinosoglou, Karolina

    Published in Antibiotics (Basel) (30-07-2023)
    “…Patients referred to intensive care units (ICU) commonly contract infections caused by multidrug-resistant (MDR) bacteria, which are typically linked to…”
    Get full text
    Journal Article
  8. 8

    Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications by Spanakis, Marios, Alon-Ellenbogen, Danny, Ioannou, Petros, Spernovasilis, Nikolaos

    Published in Pharmacy (01-08-2023)
    “…Evidence-based prescribing requires taking into consideration the many aspects of optimal drug administration (e.g., dosage, comorbidities, co-administered…”
    Get full text
    Journal Article
  9. 9

    Herpes Simplex Virus Esophagitis in a Patient Receiving Long-Term Nasal Corticosteroids: A Rare Case by Vougiouklakis, Georgios, Agouridis, Aris P, Alexakis, Konstantinos, Mamilos, Andreas, Spernovasilis, Nikolaos

    Published in Curēus (Palo Alto, CA) (11-08-2024)
    “…Herpetic esophagitis (HE), primarily caused by the herpes simplex virus (HSV)-1, is most commonly encountered in immunocompromised hosts, although it has been…”
    Get full text
    Journal Article
  10. 10

    Lomentospora prolificans: An Emerging Opportunistic Fungal Pathogen by Konsoula, Afroditi, Tsioutis, Constantinos, Markaki, Ioulia, Papadakis, Michail, Agouridis, Aris P., Spernovasilis, Nikolaos

    Published in Microorganisms (Basel) (29-06-2022)
    “…Lomentospora prolificans is an emerging opportunistic pathogen that primarily affects immunocompromised individuals leading to disseminated disease with high…”
    Get full text
    Journal Article
  11. 11

    Lomentospora prolificans Disseminated Infections: A Systematic Review of Reported Cases by Konsoula, Afroditi, Agouridis, Aris P, Markaki, Lamprini, Tsioutis, Constantinos, Spernovasilis, Nikolaos

    Published in Pathogens (Basel) (31-12-2022)
    “…, a rare, highly virulent filamentous fungus with high rates of intrinsic resistance to antifungals, has been associated with different types of infections in…”
    Get full text
    Journal Article
  12. 12

    Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations by Sarantopoulos, Andreas, Mastori Kourmpani, Christina, Yokarasa, Atshaya Lily, Makamanzi, Chiedza, Antoniou, Polyna, Spernovasilis, Nikolaos, Tsioutis, Constantinos

    Published in Tropical medicine and infectious disease (30-09-2024)
    “…The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and…”
    Get full text
    Journal Article
  13. 13

    Patient Experiences and Perceptions with Infections Due to Multidrug-Resistant Organisms: A Systematic Review by AlRawashdeh, Mousa M, Ishak, Angela, Al-Bunnia, Ahmed, Agouridis, Aris P, Lytras, Theodore, Spernovasilis, Nikolaos, Tsioutis, Constantinos

    Published in Pathogens (Basel) (22-09-2024)
    “…Infections by multidrug-resistant organisms (MDROs) pose significant public health challenges, including increased mortality rates, healthcare costs, and…”
    Get full text
    Journal Article
  14. 14

    Infections Caused by Moellerella wisconsensis : A Case Report and a Systematic Review of the Literature by Germanou, Daphnie, Spernovasilis, Nikolaos, Papadopoulos, Anastasios, Christodoulou, Sofia, Agouridis, Aris P

    Published in Microorganisms (Basel) (24-04-2022)
    “…, a member of the family of , although isolated widely in nature, rarely causes infections in humans. Herein, we report a case of isolation of from pigtail end…”
    Get full text
    Journal Article
  15. 15

    Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic-A Single-Center Retrospective Study by Ioannou, Petros, Wolff, Nora, Mathioudaki, Anna, Spanias, Christos, Spernovasilis, Nikolaos, Kofteridis, Diamantis P

    Published in Antibiotics (Basel) (01-07-2023)
    “…Dalbavancin is a semisynthetic lipoglycopeptide, which possesses great potential for bactericidal activity similar to antimicrobials with the same mechanism of…”
    Get full text
    Journal Article
  16. 16

    Factors Influencing Non-albicans Candidemia: A Case–Case–Control Study by Kofteridis, Diamantis P., Valachis, Antonis, Dimopoulou, Dimitra, Andrianaki, Angeliki M., Christidou, Athanasia, Maraki, Sofia, Spernovasilis, Nikolaos A., Samonis, George

    Published in Mycopathologia (1975) (01-08-2017)
    “…The study identified factors predisposing to non- albicans candidemia with special interest to prior antimicrobial treatment. A retrospective,…”
    Get full text
    Journal Article
  17. 17

    Assessing the knowledge, attitudes and perceptions of junior doctors on antimicrobial use and antimicrobial resistance in Greece by Spernovasilis, Nikolaos, Ierodiakonou, Despo, Milioni, Athanasia, Markaki, Lamprini, Kofteridis, Diamantis P., Tsioutis, Constantinos

    “…•A survey among all trainees and residents in Crete, Greece.•Acceptable knowledge rates (mean 60%) were found for antimicrobial use and resistance.•Excessive…”
    Get full text
    Journal Article
  18. 18

    Statins in Children with Neurofibromatosis Type 1: A Systematic Review of Randomized Controlled Trials by Agouridis, Aris P, Palli, Nikoletta, Karagiorga, Vasiliki-Eirini, Konsoula, Afroditi, Markaki, Lamprini, Spernovasilis, Nikolaos, Tsioutis, Constantinos

    Published in Children (Basel) (01-09-2023)
    “…Background: Statins, apart from their plasma-cholesterol-lowering ability, exert several pleiotropic effects, making them a potential treatment for other…”
    Get full text
    Journal Article
  19. 19
  20. 20

    COVID-19 and C. auris : A Case-Control Study from a Tertiary Care Center in Lebanon by Allaw, Fatima, Haddad, Sara F, Habib, Nabih, Moukarzel, Pamela, Naji, Nour Sabiha, Kanafani, Zeina A, Ibrahim, Ahmad, Zahreddine, Nada Kara, Spernovasilis, Nikolaos, Poulakou, Garyphallia, Kanj, Souha S

    Published in Microorganisms (Basel) (11-05-2022)
    “…Many healthcare centers around the world have reported the surge of Candida auris (C. auris) outbreaks during the COVID-19 pandemic, especially among intensive…”
    Get full text
    Journal Article